<DOC>
	<DOCNO>NCT01210521</DOCNO>
	<brief_summary>The purpose study determine effect vitamin D3 severe asthmatic patient . Vitamin D3 may alter response patient conventional steroid therapy , make responsive latter form treatment . Patients treat daily oral dose ( 2,000 IU ) vitamin D3 one month clinical serological parameter , immune function , evaluate . Results pre- post-vitaminD3 treatment compare .</brief_summary>
	<brief_title>Use Vitamin D3 Treatment Steroid Resistant Asthmatic Patients</brief_title>
	<detailed_description>Asthma one common chronic disease childhood one leading cause morbidity child . Its incidence growing , especially Western , highly industrialized nation . Glucocorticoids use treatment many inflammatory autoimmune disease , among asthma , switch gene code pro- inflammatory cytokine chemokines . Unfortunately , substantial group severe asthma patient steroid resistant . In addition , suffer long term side effect systemic steroid use . Vitamin D3 play important role maintenance several organ system deficiency cause multiple complex dysfunction organism . Vitamin D3 originally describe regulate calcemia absorb calcium intestine increase re-absorption calcium kidney . Recent study show important effect Vitamin D3 many system , especially modulator immune system , deficiency link several autoimmune inflammatory disease multiple sclerosis , inflammatory bowel disease , lupus erythematosus , rheumatoid arthritis asthma . Vitamin D inhibits dysregulated antibody synthesis see asthmatic . It inhibit proliferation immune cell produce inflammatory substance , conversely , vitamin D enhance function proliferation regulatory cell , induction IL-10 produce T regulatory cell , effective group T regulatory cell characterize CD4+ CD25+ FoxP3+ . Dendritic cell ( DC ) function also modulate Vitamin D. 1,25 ( OH ) 2vitaminD3 appear generate tolerogenic dendritic cell ( DC ) vivo , demonstrate model transplantation autoimmune disease . Immature/tolerogenic DCs induce development T regulatory cell several mechanism , include production IL-10 TGF-beta . Vitamin D3 increase glucocorticoid receptor expression asthmatic patient ' T cell . In interest study asthma mouse model , treatment Vitamin D combine immunotherapy result increased production inhibitory cytokine IL-10 lung tissue increase level TGF-beta serum . Overall study others , support hypothesis Vitamin D induce regulatory T cell crucial control autoimmune diseases asthma . In spite attractive conceptual link benefit vitamin D immune regulation SR asthma , study present clinical data , i.e. , pulmonary function , quality life score , reduction steroid dose medication , index well asthma control . There also dearth ex-vivo data order confirm refute in-vitro result . There little data characterizes effect vitamin D supplementation immune cell , cytokine , asthma mediator .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Diagnosis severe steroid resistant asthmatic define American Thoracic Society workshop 2000 . Patients must diagnose least one year prior study . Patients must exhibit one major criterion two minor criterion follow list include study : Definition Severe Asthma American Thoracic Society Consensus ( 2000 ) . Major Characteristics In order achieve control level mildmoderate persistent asthma : 1 . Treatment continuous near continuous ( &gt; 50 % year ) oral corticosteroid 2 . Requirement treatment highdose inhaled corticosteroid : Drug Dose ( µg/d ) Dose ( puffs/d ) 1 . Beclomethasone dipropionate . &gt; 1,260 . &gt; 40 puff ( 42 µg /inhalation ) . &gt; 20 puff ( 84 µg/inhalation ) 2 . Budesonide &gt; 1,200 &gt; 6 puff 3 . Flunisolide &gt; 2,000 &gt; 8 puff 4 . Fluticasone propionate &gt; 880 &gt; 8 puff ( 110µg ) , &gt; 4puffs ( 220 µg ) 5 . Triamcinolone acetonide &gt; 2,000 &gt; 20 puff Minor Characteristics 1 . Requirement daily treatment controller medication addition inhale corticosteroid , e.g. , longacting βagonist , theophylline , leukotriene antagonist 2 . Asthma symptoms require shortacting βagonist use daily near daily basis 3 . Persistent airway obstruction ( FEV1,80 % predict ; diurnal PEF variability &gt; 20 % ) 4 . One urgent care visit asthma per year 5 . Three oral steroid `` burst '' per year 6 . Prompt deterioration &lt; 25 % reduction oral inhale corticosteroid dose 7 . Near fatal asthma event past Additional minor characteristic include : normal diffuse capacity methacholine PC20 le 8mg . Patients diagnose follow condition exclude : Vitamin D resistant rickets , chronic renal failure , hypercalcemia ( secondary hyperparathyroidism malignancy ) , Chronic Obstructive Pulmonary Disease , severe malabsorption syndrome , sarcoidosis , patient take cardiac glycoside cardiac arrythmias . Pregnant nursing woman , smoke patient exclude .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Asthmatic Patients</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Steroid Resistant Asthmatic Patients</keyword>
	<keyword>cholecalciferol</keyword>
</DOC>